Author: Ahmad, Suhana; Hatmal, Ma'mon M.; Lambuk, Lidawani; Al-Hatamleh, Mohammad A.I.; Alshaer, Walhan; Mohamud, Rohimah
Title: The role of TNFR2(+) Tregs in COVID-19: An overview and a potential therapeutic strategy Cord-id: v2k9kj7v Document date: 2021_10_19
ID: v2k9kj7v
Snippet: COVID-19 is a multi-faceted disease ranging from asymptomatic to severely ill condition that primarily affects the lungs and could advance to other organs as well. It's causing factor, SARS-CoV-2 is recognized to develop robust cell-mediated immunity that responsible to either control or exaggerate the infection. As an important cell subset that control immune responses and are significantly dysregulated in COVID-19, Tregs is proposed to be considered for COVID-19 management. Among its hallmark,
Document: COVID-19 is a multi-faceted disease ranging from asymptomatic to severely ill condition that primarily affects the lungs and could advance to other organs as well. It's causing factor, SARS-CoV-2 is recognized to develop robust cell-mediated immunity that responsible to either control or exaggerate the infection. As an important cell subset that control immune responses and are significantly dysregulated in COVID-19, Tregs is proposed to be considered for COVID-19 management. Among its hallmark, TNFR2 is recently recognized to play important role in the function and survival of Tregs. This review gathers available TNFR2 agonists to directly target Tregs as a potential approach to overcome immune dysregulation that affect the severity in COVID-19. Furthermore, this review performs a rigid body docking of TNF-TNFR2 interaction and such interaction with TNFR2 agonist to predict the optimal targeting approach.
Search related documents:
Co phrase search for related documents- activation entry and acute ards respiratory distress syndrome: 1
- activation entry and lung damage: 1, 2
- acute ards respiratory distress syndrome and adaptive immunity: 1, 2, 3, 4, 5, 6, 7
- acute ards respiratory distress syndrome and lung abundant: 1
- acute ards respiratory distress syndrome and lung damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute ards respiratory distress syndrome and lung damage repair: 1, 2, 3, 4, 5
- acute ards respiratory distress syndrome and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute lung injury and adaptive immunity: 1, 2, 3, 4, 5, 6
- acute lung injury and lung abundant: 1, 2, 3
- acute lung injury and lung damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute lung injury and lung damage repair: 1, 2
- acute lung injury and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute lung injury cause and lung abundant: 1
- acute lung injury cause and lung damage: 1, 2, 3, 4, 5, 6
- acute lung injury cause and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- adaptive immunity and lung abundant: 1
- adaptive immunity and lung damage: 1, 2, 3, 4, 5, 6, 7, 8, 9
- adaptive immunity and lung injury: 1, 2, 3, 4, 5, 6, 7
- adaptive immunity and lymphoid myeloid: 1, 2
Co phrase search for related documents, hyperlinks ordered by date